Science Group hikes share buyback programme despite dip in revenue Science Record profit first half profit at Science Group driven by a well choreographed turnaround at one of its major brands helped the consultancy and systems specialist to increase its share buyback programme.
British Patient Capital invests £90m London biotech company Tech British Patient Capital recently also invested £10m into biotech firm Curve Therapeutics to support its cancer drug discovery technology.
Life sciences Syncona struggles on amid oncology investments Investment Life sciences investor Syncona is banking on a recovery in biotech as it has struggled to keep up its share price over recent years.
Election 2024: Labour will be ‘partner’ not ‘barrier’ to innovation June 11, 2024 A Labour government will be a “partner that can unlock potential”, not a “barrier” to innovation, shadow minister Peter Kyle has pledged.
Life Science REIT slashes dividend after value of portfolio sinks March 26, 2024 Life Sciences REIT has halved its dividend for 2023 after the value of its portfolio fell considerably throughout the year.
How Liverpool hopes to create 8,000 jobs and ‘save lives across the world’ March 12, 2024 Details of how Liverpool's Investment Zone will seek to create 8,000 jobs and 'save lives across the world' have been unveiled.
Britain and Germany to sign science and tech research deal in post-Brexit leap after rejoining Horizon March 12, 2024 The UK and Germany will sign a fresh agreement to boost their joint science and technology research, the government has announced.
Public investment in Canary Wharf is a vote of confidence in British business March 10, 2024 British life sciences are a beacon of hope with the power to transform lives, but to realise their full potential, the public and private sectors must work together, says minister of state Andrew Griffith The UK’s life sciences sector is a true British success story. For millions of people across the country who are facing [...]